MKI67 and neoplasm: As inflammation triggers tumor proliferation, we used Ki67 as a proliferation marker and observed significant decrease (38.6%, p < 0.05) in the genistein group, compared to the control group, when Ki67 signal was divided by the number of DAPI-positive signals (Fig. 4b).